Is Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) a Stock to Watch After Losing -5.90% This Week?

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock is lower by 5.90% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Bio-Rad Laboratories, Inc. Class A Common Stock has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on BIO!

See Full BIO Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With BIO Stock Today?

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock is trading at $624.05 as of 2:29 PM on Friday, Jan 14, a drop of -$16.72, or -2.61% from the previous closing price of $640.77. The stock has traded between $619.87 and $641.45 so far today. Volume today is low. So far 80,975 shares have traded compared to average volume of 128,770 shares. To screen for more stocks like Bio-Rad Laboratories, Inc. Class A Common Stock click here.

More About Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (60% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the United States (40% of 2020 sales), Europe (34%), and Asia (21%), with Canada and Latin America accounting for the bulk of the remaining 5%. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. Click Here to get the full Stock Report for Bio-Rad Laboratories, Inc. Class A Common Stock stock.